LLY vs MAC · P/E 39, rev $65.18B vs rev $918.2M
Eli Lilly and Company (LLY) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MAC currently screens at market cap $4.41B.
Not investment advice. Open the LLY and MAC stock pages for the full models.
Not investment advice.